Fresh2 Group Ltd (FRES) Stock

DelistedNasdaq: FRESFresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China.

0.85
Final close · Dec 23, 2024

FRES is no longer traded. Fresh2 Group was delisted from the Nasdaq in December 2024.

Prices on this page are historical; the last trade was December 23, 2024 at $0.85.

Fresh2 Group stock price history

Split-adjusted closes, 2023–2024

FRES final trading statistics

Final close
$0.85
Final trading day
Dec 23, 2024
Market cap at delisting
$2.08M
Shares outstanding
2.45M
Final 52-week range
$0.27 – $3.40
Avg. volume (final 3 mo.)
27,012
All-time high (split-adj.)
$2128.00 · Feb 2020
All-time low (split-adj.)
$0.06 · Jan 2020
Return since IPO
+1409.8%
Beta
1.28
Book value / share
$103.01
Price / book
0.01
Final 52 wk
0.273.40

Fresh2 Group earnings per share

Earnings per share

Fresh2 Group revenue & net income

RevenueNet income

Fresh2 Group annual financials

Fresh2 Group Ltd revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$12.04M-$101.9M—
FY2021$17.75M-$117.2M—
FY2020$19.39M-$76.1M-$85.61
FY2019$10.82M-$100.8M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Fresh2 Group Ltd

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Fresh2 Group stock FAQ

What happened to Fresh2 Group stock?

Fresh2 Group stock was delisted from the Nasdaq. Its final close was $0.85 on December 23, 2024.

Is FRES stock still trading?

No. FRES was delisted from the Nasdaq in December 2024 and no longer trades on a U.S. exchange.

What was the last price of FRES stock?

FRES closed at $0.85 on its final trading day, December 23, 2024, for a market value of about $2.08M.

What were Fresh2 Group's revenue and earnings in its last full fiscal year?

Fresh2 Group reported revenue of $12.04M and net income of -$101.9M in fiscal 2022, its last full year as a public company.

When did Fresh2 Group go public?

Fresh2 Group Ltd stock began trading on May 22, 2023.

Diagnostics & Research stocks to research

All Healthcare stocks →